OCULAR SURFACE DISEASE ALLEVIATED WITH DUPILUMAB: A CASE SERIES

被引：0
|
作者：
Chen, J.
Bielory, L.
机构：
来源：
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY | 2022年 / 129卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
P248
引用
收藏
页码：S80 / S81
页数：2
相关论文
共 50 条
  • [41] Dupilumab and conjunctivitis: a case series of twenty patients
    Calabrese, G.
    Gambardella, A.
    Licata, G.
    Di Brizzi, E. V.
    Alfano, R.
    Argenziano, G.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2021, 35 (09) : E612 - E614
  • [42] Immediate hypersensitivity to dupilumab: A French case series
    Lemery, Romain
    Cariou, Claire
    Darrigade, Anne-Sophie
    Rochefort-Morel, Cecile
    Carvalho-Lallement, Priscille
    Tedbirt, Billal
    Polard, Elisabeth
    Picard, Sylvie
    Bergeron, Sandrine
    Sanchez-Pena, Paola
    Dupuy, Alain
    Triquet, Louise
    Droitcourt, Catherine
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2023, 11 (08): : 2608 - 2610
  • [43] Vitiligo induced by dupilumab treatment: A case series
    Ren, Hongyi
    Akabane, Andressa L.
    Kelleher, Kiera
    Halverstam, Caroline
    Hicks, Maria
    Schachter, Jordana R.
    Silverman, Robert
    Chachkin, Samuel
    Sherman-Bergman, Shany
    Harris, John E.
    Kuohung, Victoria
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2023, 37 (11) : 2259 - 2261
  • [44] Dupilumab as an adjunct to surgery in patients with aspirin-exacerbated respiratory disease: a case series
    Patel, Pooja
    Bensko, Jillian
    Laidlaw, Tanya
    Buchheit, Kathleen
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2021, 147 (02) : AB133 - AB133
  • [45] Reduction in the incidence of dupilumab-induced ocular surface disease by a preventative topical eye treatment regime
    Babakinejad, P.
    Bajwa, D. S.
    Reynolds, N. J.
    Ball, S.
    Pradhan, S.
    Figueiredo, F. C.
    Meggitt, S.
    BRITISH JOURNAL OF DERMATOLOGY, 2021, 185 : 41 - 41
  • [46] Tear fluid dupilumab levels of patients with moderate-to-severe atopic dermatitis and ocular surface disease
    Achten, R.
    Thijs, J.
    van Luijk, C.
    van Wijk, F.
    van Luin, M.
    El Amrani, M.
    Delemarre, E.
    de Graaf, M.
    Bakker, D.
    de Boer, J.
    de Bruin-Weller, M.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2022, 142 (12) : S196 - S196
  • [47] Comment on: ‘Dupilumab-associated ocular surface disease: presentation, management and long-term sequelae’
    Tomoyuki Kawada
    Eye, 2022, 36 : 1515 - 1515
  • [48] IgG4-related disease administered dupilumab: case series and review of the literature
    Kanda, Masatoshi
    Kamekura, Ryuta
    Sugawara, Masanari
    Nagahata, Ken
    Suzuki, Chisako
    Takano, Kenichi
    Takahashi, Hiroki
    RMD OPEN, 2023, 9 (01):
  • [49] Comment on: 'Dupilumab-associated ocular surface disease: presentation, management and long-term sequelae'
    Kawada, Tomoyuki
    EYE, 2022, 36 (07) : 1515 - 1515
  • [50] DupilumabFacial redness and ocular surface disease: case report
    Reactions Weekly, 2020, 1833 (1) : 165 - 165
12345